Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BeyondMD vs PepHaūs

By GLP-1 ScorecardUpdated

BeyondMD
Site position #193

Lower score

PepHaūsFactor scores not reassessed.
Site position #25

Higher score

Score comparison

PepHaūs has the higher recorded score — 82.7/100 to 66.8/100.

PepHaūs grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Compare monthly billing with prepaid commitments, then confirm renewal pricing and supply.

Before you choose

BeyondMD does not publish a semaglutide price, so its BeyondMD review sets out what it does disclose, while the PepHaūs review explains the conditions attached to PepHaūs's figure. The semaglutide cost page compares published rates across the field. Ask BeyondMD for a written total before treating either one as the cheaper choice.

If neither one fits, BeyondMD vs Piper and Blis MD vs PepHaūs compare each of them with another graded program, and the list of alternatives to BeyondMD ranks the programs closest to BeyondMD on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the Direct Meds review covers one graded close to these two, at 77.6/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valuePepHaūs +6
76
82
Dose & formulationPepHaūs +16
64
80
Clinical oversightPepHaūs +10
74
84
Labs & monitoringPepHaūs +29
53
82
FulfillmentPepHaūs +21
65
86
Contract termsPepHaūs +30
55
85
BeyondMD · top barPepHaūs · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricBeyondMDPepHaūs
WeighScore66.8/10082.7/100
GradeCB−
Site position#193#25
SemaglutideNot verified (current medication-specific quote required)$169 monthly; prepaid plans available (advertised)
TirzepatideNot verified (current medication-specific quote required)$239 monthly; prepaid plans available (advertised)
CoverageAdvertises broad US coverage; confirm treatment and state availabilityClaims all 50 states plus DC; treatment eligibility requires confirmation
Brand-name accessYesNot confirmed
Oral / sublingualYesNot confirmed
BeyondMD

Site position #193 · C

Strengths

  • Injection and oral GLP-1 programs advertised
  • Wegovy and Zepbound consultation routes listed
  • Optional specialist and nutrition contacts described

What to consider

  • Current medication-specific monthly prices not verified
  • Consultation fees generally retained after clinical work starts, even if treatment is declined
  • Medication refunds generally end at pharmacy processing
  • Assigned practice, dispenser and treatment-specific state eligibility need confirmation
PepHaūs

Site position #25 · B−

Factor scores not reassessed.

Strengths

  • Publishes monthly and prepaid plan amounts
  • Names provider and pharmacy partners

What to consider

  • Price-lock wording needs reconciling with renewal terms
  • Actual supply and longer-plan shipments remain unverified
  • Independent license and certification status remain unverified

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard